Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
US12371435B2 · kind B2 · utility
0Cited by
27References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 26, 2022 |
| Grant date | Jul 29, 2025 |
| Priority date | — |
| Expiry date | Aug 26, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to a process for the preparation of a compound of Formula (G), comprising reacting a compound of Formula (H) with a compound of Formula (D) in the presence of a palladium catalyst to afford the compound of Formula (G).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.